A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases-Reference-Cited by-同舟云学术

A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

Published:2019-02-26 Issue:4 Volume:7 Page:714-718
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Nakamura Naohiko¹^ORCID,Kinami Shinichi¹^ORCID,Fujii Yoritaka¹^ORCID,Miura Seiko¹^ORCID,Fujita Jun¹^ORCID,Kaida Daisuke¹^ORCID,Tomita Yasuto¹^ORCID,Miyata Takashi¹^ORCID,Fujita Hideto¹^ORCID,Ueda Nobuhiko¹^ORCID,Kosaka Takeo¹^ORCID

Affiliation:

1. Department of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2056

Reference11 articles.

1. Global Patterns of Cancer Incidence and Mortality Rates and Trends

2. Japanese Gastric cancer treatment guidelines 2014 (ver.4);Japanese Gastric Cancer Association;Gastric Cancer,2016

3. Present and Future Status of Gastric Cancer Surgery

4. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

5. Standard first‐line chemotherapy for metastatic gastric cancer in Japan has met the global standard: evidence from recent phase III trials;Takashima A;Gastrointest Cancer Res,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy

;Cancer Management and Research;2020-05

2. Cisplatin;Reactions Weekly;2019-05